Zobrazeno 1 - 10
of 58
pro vyhledávání: '"WEI-PING YUAN"'
Publikováno v:
Applied Sciences, Vol 13, Iss 2, p 817 (2023)
For larger-scale quantum information processing, qubit reset plays an important role, as the coherent times for qubits are limited. However, previous schemes require either long reset times or a complex pulse calibration technique, leading to low eff
Externí odkaz:
https://doaj.org/article/eac671b297b74efab59fde7ecb54ed80
Autor:
Jian-Hong Zhong, Xin-Shao Mo, Bang-De Xiang, Wei-Ping Yuan, Jin-Fang Jiang, Gui-Sheng Xie, Le-Qun Li
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58082 (2013)
AimTo evaluate the chemopreventive efficacy of vitamin K2 (VK2) analog in patients with hepatocellular carcinoma (HCC) after curative hepatic resection or local ablation, since a recent randomized control trial (RCT) and systematic review have given
Externí odkaz:
https://doaj.org/article/d68bf9e1c45f430bac18b6bbf9b63b4b
Autor:
Juan, Gao, Shuang, Yang, Yu-Xia, Wang, Ya-Nan, Gao, Ya-Jing, Chu, Wei-Ping, Yuan, Xiao-Min, Wang
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 30(1)
To investigate the effect of Rheb1 in the development of mouse megakaryocyte-erythroid progenitor cells and its related mechanism.Rheb1 was specifically knocked-out in the hematopoietic system of Vav1-Cre;Rheb1After Rheb1 was knocked out, the develop
Autor:
Ping-Ping Guo, Bang-De Xiang, Kang Chen, Lei Liu, Zhu-Jian Deng, Lu-Nan Qi, Zhi-Ming Zhang, Jian-Hong Zhong, Xiu-Mei Liang, Shan Huang, Le-Qun Li, Wei-Ping Yuan, Wei Wei, Wen-Feng Gong, Le Li, Liang Ma
Publikováno v:
Cancer immunology, immunotherapy : CII. 71(5)
Lenvatinib is regarded as the first-line therapy for patients with unresectable hepatocellular carcinoma (HCC). This study assessed the efficacy and safety of lenvatinib with or without immune checkpoint inhibitors (ICIs) in patients with unresectabl
Autor:
Wen-Qi Wu, Xiao-Min Wang, Xiaofan Zhu, Wenbin An, Chao Liu, Lixian Chang, Yingchi Zhang, Aoli Zhang, Yang Wan, Chunmin Huang, Xingjie Gao, Min Gao, Yuxia Wang, Wei-Ping Yuan
Publikováno v:
Blood Science, Vol 3, Iss 3, Pp 71-77 (2021)
Fanconi anemia (FA), an X-linked genetic or autosomal recessive disease, exhibits complicated pathogenesis. Previously, we detected the mutated Dynein Axonemal Heavy Chain 2 (DNAH2) gene in 2 FA cases. Herein, we further investigated the potential as
Autor:
Yu-Jie, Bian, Wei-Wang, Li, Meng-Ke, Li, Bi-Chen, Wang, De-Yang, Shi, Jun, Shi, Wei-Ping, Yuan, Ya-Jing, Chu
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 29(2)
Objective: To establish an acquired aplastic anemia animal model for investigating the function of T lymphocyte and the pathogenesis and treatment of aplastic anemia(AA).To establish the acquired aplastic anemia mouse model through the X-ray irradiat
Autor:
Xue-Mei You, Bang-De Xiang, Xu Liu, Cai-Yi He, Jing Cui, Rong-Rui Huo, Yang Yang, Jian-Hong Zhong, Liang Ma, Le-Qun Li, Kun-Hua Huang, Wei-Ping Yuan
Publikováno v:
Bioscience Reports
Background and aim: Assessing the average survival rate of patients with hepatocellular carcinoma (HCC) after hepatectomy is important for making critical decisions in everyday clinical practice. The present study aims to develop and validate a nomog
Autor:
Ning Fu Peng, Ru Hong Li, Le Qun Li, Wei Ping Yuan, Tian Yang, Jian-Hong Zhong, Bao Hong Yuan, Tiejun Tong
Publikováno v:
Oncotarget
The harms and benefits of adoptive immunotherapy (AIT) for patients with postoperative hepatocellular carcinoma (HCC) are controversial among studies. This study aims to update the current evidence on efficacy and safety of AIT for patients with HCC
Autor:
Qiong He, null 何琼, null 王惠荟, null 程涛, null 袁卫平, null 马钰波, null 蒋永平, null 任志华, Hui-hui Wang, Tao Cheng, Wei-ping Yuan, Yu-po Ma, Yong-ping Jiang, Zhi-hua Ren
Publikováno v:
Chinese Medical Sciences Journal. 32:135-144
Objective To genetically correct a disease-causing point mutation in human induced pluripotent stem cells (iPSCs) derived from a hemophilia B patient. Methods First, the disease-causing mutation was detected by sequencing the encoding area of human c
Publikováno v:
Translational Cancer Research
Conventional transarterial chemoembolization (cTACE) and sorafenib are the standard monotherapy for patients with hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) stage B or C by Western official guidelines (1,2). Many large ran